Calliditas Therapeutics A... (CALT)
NASDAQ: CALT
· Real-Time Price · USD
40.00
-0.04 (-0.10%)
At close: Sep 20, 2024, 10:00 PM
Calliditas Therapeutics AB (publ) Cash Flow Statement
Financials in SEK. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -47.48M | -203.83M | -18.37M | -159.57M | -75.17M | -187.53M | 32.49M | -36.23M | -209.84M | -208.37M | -222.13M | 7.86M | -159.4M | -150.78M |
Depreciation & Amortization | n/a | n/a | 16.59M | n/a | n/a | n/a | 12.91M | n/a | n/a | n/a | 6.46M | n/a | n/a | n/a |
Stock-Based Compensation | n/a | n/a | 52.59M | n/a | n/a | n/a | 35.79M | n/a | n/a | n/a | 21.96M | n/a | n/a | n/a |
Other Working Capital | n/a | 13.62M | -28.12M | 60.16M | -49.56M | -62.22M | 271.95M | -85.05M | -21.13M | 17.29M | 26.56M | -49.21M | 17.32M | 11.75M |
Other Non-Cash Items | 72.84M | 16.26M | 69.33M | 36.88M | -38.3M | 17.8M | 20.22M | -3.44M | 5.74M | -341K | 35.27M | 8.11M | 9.17M | 4.85M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -48.7M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -32.41M | 13.62M | -28.12M | 60.16M | -49.56M | -62.22M | 177.32M | -85.05M | -21.13M | 17.29M | 25.61M | -49.21M | 17.32M | 11.75M |
Operating Cash Flow | -7.04M | -198.21M | 22.84M | -62.53M | -163.03M | -231.94M | 230.03M | -124.72M | -225.23M | -191.42M | -161.25M | -33.24M | -132.91M | -134.18M |
Capital Expenditures | n/a | n/a | -12.79M | n/a | n/a | n/a | -2.51M | n/a | n/a | n/a | -6.59M | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -39.02M | n/a | 2.28M | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -3.86M | 11.39M | -7.42M | -1.06M | -2.91M | 1.05M | -888K | -139K | -2.65M | -5.34M | -236K | -18.57M | -199K |
Investing Cash Flow | -102K | -3.86M | -2.35M | -7.42M | -1.06M | -2.91M | -1.47M | -888K | -139K | -2.65M | -5.34M | -236K | -18.57M | -199K |
Debt Repayment | -4.06M | -5.47M | 235.15M | -2.89M | -3.02M | -2.97M | 252.42M | -2.57M | 233.94M | -1.66M | -2.27M | 197.58M | -351K | -1.01M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -236K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -26.63M | n/a | n/a | n/a | 30.22M | n/a | 1.93M | 61.71M | -39.02M | -34.78M | -366K | -8.62M |
Financial Cash Flow | -4.05M | -5.47M | 208.52M | -2.89M | -3.02M | -2.97M | 282.64M | -2.57M | 235.87M | 60.05M | -41.29M | 486.8M | -717K | -9.63M |
Net Cash Flow | -13.04M | -163.42M | 186.85M | -79.3M | -147.42M | -235.49M | 512.93M | -110.64M | 21.39M | -130.1M | -208.31M | 454.51M | -158.04M | -128.96M |
Free Cash Flow | -7.04M | -198.21M | 10.06M | -62.53M | -163.03M | -231.94M | 227.52M | -124.72M | -225.23M | -191.42M | -167.84M | -33.24M | -132.91M | -134.18M |